Lv4
490 积分 2023-01-29 加入
Abstract 3500: LBL-054-CD3: An anti-CDH17 and CD3 bispecific antibody for the treatment of CDH17-positive gastrointestinal cancer
6小时前
求助中
Low-dose IL-2 therapy in autoimmune diseases: An update review
7天前
已完结
Lymph nodes fuel KLF2-dependent effector CD8+ T cell differentiation during chronic infection and checkpoint blockade
22天前
已完结
Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28
1个月前
已完结
Reprogramming intratumoral T reg cells by morpholino-mediated splicing of FOXP3 for cancer immunotherapy
2个月前
已完结
T-cell death and cancer immune tolerance
2个月前
已完结
Architects of immunity: How dendritic cells shape CD8 + T cell fate in cancer
6个月前
已完结
The diversity of CD8+ T cell dysfunction in cancer and viral infection
6个月前
已完结
A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals
6个月前
已完结
Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response
11个月前
已完结
皖公网安备34019202002308
